市場調査レポート
商品コード
1159392
サブユニットワクチンの世界市場(2022年~2028年)Subunit Vaccine Market 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
サブユニットワクチンの世界市場(2022年~2028年) |
出版日: 2022年10月20日
発行: Orion Market Research
ページ情報: 英文 110 Pages
納期: 2~3営業日
|
世界のサブユニットワクチンの市場規模は、予測期間中に10.9%の大幅なCAGRで成長すると予測されています。市場の成長を後押しする主な要因には、予防接種の需要増加、従来のワクチンと比較した際の安全性の向上、サブユニットワクチンが提供する利点などが挙げられます。一方で、サブユニットワクチンの生産プロセスに関連する課題が、市場の成長を妨げています。
当レポートでは、世界のサブユニットワクチン市場を調査しており、市場の概要、市場動向の分析、製品タイプ別・生産タイプ別・免疫応答タイプ別・疾患別・地域別の分析、競合情勢、さらに主要企業のプロファイルなど、包括的な情報を提供しています。
Title:Global Subunit Vaccine Market Size, Share & Trends Analysis Report, by Product Type (Protein Antigen, and Polysaccharide Antigen), by Production Type (Denaturing of Proteins, and Genetic Engineering), by Immune Responses Type (Antigen-Presenting Cells (APCs), Cell-Mediated Immunity, Cytokines, Mucosal, and Others), and by Disease (Infectious Disease, Diphtheria, Tetanus and Pertussis (DTP), HPV, Measles, Mumps and Rubella (MMR), and Others) Forecast Period (2022-2028).
The global subunit vaccine market is anticipated to grow at a significant CAGR of 10.9% during the forecast period. The factors fueling the growth of the subunit vaccine market include increasing demand for immunization and better safety as compared to traditional vaccines. The benefits offered by subunit vaccines such as long immunity offered and the low-risk rate associated with the subunit vaccines are propelling the market growth. The challenges associated with the production process of subunit vaccines are hindering the growth of the market.
The global subunit vaccine market is segmented based on the product type, production type, immune response type, and disease. Based on the product type, the market is segmented into protein antigen and polysaccharide antigen. Based on the production type, the market is segmented into denaturing of proteins, and genetic engineering. Based on the type of the immune response, the market is segmented into antigen-presenting cells (APCs), cell-mediated immunity, cytokines, mucosal, and others. Based on the disease, the market is sub-segmented into infectious disease, diphtheria, tetanus and pertussis (DTP), HPV, measles, mumps, and rubella (MMR), and others. The above-mentioned segments can be customized as per the requirements. Based on the production type, the global subunit vaccines market is classified into denaturing of proteins and genetic engineering. The denaturing of proteins segment held a considerable market share owing to the easy production process.
Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is the leading market for subunit vaccines owing to increased technological advancements and R&D.
The major companies serving the global subunit vaccine market include GE Healthcare Life Sciences, GlaxoSmithKline PLC, Merck & Co. Inc., Reber Genetics, Sanofi S.A., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2019, a private biotechnology company, Algenex SL, delivered disruptive technology for recombinant biologics manufacturing and announced that one of its industrial partners has submitted a dossier to the European Medicines Agency (EMA) for a recombinant subunit vaccine manufacturing by using Algenex' proprietary CrisBio® technology. The submission targeted European marketing authorization through the centralized approval system. This was the first vaccine manufactured using Algenex' CrisBio® technology to be submitted for regulatory approval.
Research Methodology
The market study of the global subunit vaccine market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers: